Lowering Plasma Cholesterol by Raising LDL Receptors
- 27 August 1981
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 305 (9) , 515-517
- https://doi.org/10.1056/nejm198108273050909
Abstract
More than 93 per cent of the body's cholesterol is located in cells, where it performs vital structural and metabolic functions; only about 7 per cent circulates in plasma, where it predisposes to atherosclerosis. All the cholesterol in plasma is packaged within lipoprotein particles; two thirds is in low-density lipoprotein (LDL). Epidemiologic data and animal experiments indicate that plasma LDL is a major cause of atherosclerosis, particularly in the one of every 500 members of the population who has familial hypercholesterolemia. Because of their elevated LDL levels, male heterozygotes with this dominant disease have an 85 per cent chance of . . .Keywords
This publication has 12 references indexed in Scilit:
- Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1981
- Regulation of Plasma Cholesterol by Lipoprotein ReceptorsScience, 1981
- Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo.Proceedings of the National Academy of Sciences, 1981
- Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.Proceedings of the National Academy of Sciences, 1981
- Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proceedings of the National Academy of Sciences, 1980
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980
- Therapeutic effects of ML-236B in primary hypercholesterolemiaAtherosclerosis, 1980
- The Low-Density Lipoprotein Pathway and its Relation to AtherosclerosisAnnual Review of Biochemistry, 1977
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976
- Regulation of Cholesterol MetabolismNew England Journal of Medicine, 1970